Clinical Trials

Other solid neoplasmThoracic

186 enrolled

Mesothelioma, Malignant, Mesothelioma, Pleural Effusion, Malignant

NCT05987189 2024-01-16

Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung

2,000 enrolled

Lung Neoplasms

NCT04450732 2023-12-05

Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors

96 enrolled

GastrointestinalThoracic

Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT04632758 2023-11-24

Study Comparing WX-0593 to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients

292 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05329025 2023-11-24

A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05669105 2023-11-22

Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental Research

200 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05673590 2023-11-08

Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

612 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05863325 2023-11-07

A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC)

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05094804 2023-11-02

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

DermatologicHead & NeckSarcomaThoracic

172 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Leiomyosarcoma, Liposarcoma, Melanoma, Neoplasm Metastasis, Neoplasms

NCT06110663 2023-11-01

A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy

314 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05498597 2023-10-19

AMT-151 in Patients With Selected Advanced Solid Tumours

BreastGynecologicOther solid neoplasmThoracic

30 enrolled

Adenocarcinoma of Lung, Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Carcinoma, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05482568 2023-10-16

A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer

324 enrolled

Advanced Non-small Cell Lung Cancer

NCT04726215 2023-09-29

Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05728619 2023-09-28

HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer

64 enrolled

Recurrent Extensive Stage Small Cell Lung Carcinoma

NCT05347628 2023-08-21

Assessing the Safety and Efficacy of PLB1004 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

91 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03215693 2023-08-16

X-396 Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib

152 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05102214 2023-08-08

HLX301 (TIGIT×PDL1 Bispecific) in Patients With Locally Advanced or Metastatic Solid Tumors

150 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05360381 2023-08-08

HLX35(EGFR×4-1BB Bispecific) in Patients With Advanced or Metastatic Solid Tumors

Other solid neoplasmThoracic

82 enrolled

Locally Advanced or Metastatic Solid Tumors

NCT05739006 2023-08-02

Clinical Trial to Evaluate the PK and Safety of BCD-201 and Keytruda® in Patients With Advanced Malignancies

Phase EARLY_PHASE1 Unknown

131 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT05648955 2023-07-28

ALLIES

118 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT05731518 2023-07-14

SC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

67 enrolled

Small Cell Lung Carcinoma

NCT05708950 2023-07-13

A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

314 enrolled

Breast Neoplasms, Carcinoma, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Uterine Neoplasms

NCT05870592 2023-07-11

Detection of Abnormal Respiratory Cell Populations in Lung Cancer Screening Patients Using the CyPath Lung Assay

40 enrolled

Lung Neoplasms

NCT04763083 2023-07-07

First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies

DermatologicLymphoidOther hematologic neoplasmThoracic

90 enrolled

Carcinoma, Non-Small-Cell Lung, Lymphoma, Follicular, Melanoma, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05127590 2023-07-03

RBN-2397 in Combination With Pembrolizumab in Patients With SCCL

50 enrolled

Advanced Squamous Non-Small Cell Lung Carcinoma

NCT05900219 2023-06-12

Efficacy and Safety of HL-085 Combined With Vemurafenib in BRAF V600E Patients With Non-small Cell Lung Cancer: a Phase II Clinical Study

75 enrolled

Phase EARLY_PHASE1 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05886075 2023-06-02

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors

24 enrolled

BreastGastrointestinalGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT05498389 2023-06-01

EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer

115 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03797391 2023-05-31

A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

186 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms

NCT04462185 2023-05-24

A Prospective Cohort Study of Chinese Patients With Pulmonary Nodules: Prediction of Lung Cancer Using Noninvasive Biomarkers

3,000 enrolled

Lung Neoplasms, Multiple Pulmonary Nodules

NCT04580498 2023-05-19

A Trial of SHR-1701 With or Without Chemotherapy in Patients With Stage III NSCLC

107 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05859373 2023-05-16

To Evaluate the Efficacy and Safety of TQB3728 Tablets in Sequential Maintenance of TQB2450 Injection Therapy in Patients After Sequential or Concurrent Chemoradiation for Locally Advanced Non-small Cell Lung Cancer.

78 enrolled

Phase EARLY_PHASE1 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05860374 2023-05-16

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors

20 enrolled

BreastGastrointestinalSarcomaThoracic

Breast Neoplasms, Carcinoma, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms

NCT04348643 2023-04-18

Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer

BreastGastrointestinalThoracic

40 enrolled

Breast Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT05641493 2023-04-10

A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of HLX208+HLX10 in NSCLC With BRAF V600E Mutation

49 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05801107 2023-04-06

Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05555212 2023-03-28

To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation

72 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05741021 2023-02-24

A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

84 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05430386 2023-02-14

Study of HS-10241 in Combination With Almonertinib in Patients With Locally Advanced or Metastatic NSCLC

174 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05715398 2023-02-10

BR790 in Combination With Anlotinib in Adult Subjects With Advanced Non-Small Cell Lung Cancer

90 enrolled

Carcinoma, Non-Small-Cell Lung, Noonan Syndrome

NCT02981108 2023-01-23

A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC

364 enrolled 29 charts

Carcinoma, Non-Small-Cell Lung

NCT03849768 2023-01-20

A Study to Evaluate Safety and Efficacy of HS-10296 as First-Line Treatment in Patients

429 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung

NCT05685524 2023-01-17

Clinical Study of Pan-cancer DNA Methylation Test in Plasma

GastrointestinalGenitourinaryGynecologicHead & NeckThoracic

3,000 enrolled

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT05661240 2022-12-22

Phase Ⅱ/Ⅲ Clinical Study of Tumor Treating Fields （EFE-P100）Combined With Docetaxel in the Treatment of Stage IV Non-small Cell Lung Cancer Patients With Disease Progression After Platinum-based Chemotherapy and Anti-programmed Death 1（PD-1)/Programmed Cell Death-Ligand 1(PD-L1) Antibody Treatment

Phase 2/3 Unknown

348 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05651269 2022-12-15

Milciclib in Combination With Gemcitabine in Advanced NSCLC

28 enrolled